by MEGIN | Feb 27, 2025 | MEGIN News
LONDON, UK. February 27th, 2025 – MYndspan, a pioneer in consumer brain health technology, announced a new partnership today with MEGIN, the global leader in magnetoencephalography (MEG), to make high-precision brain scanning more widely available. This collaboration...
by MEGIN | Jul 1, 2024 | MEGIN News
MEGIN, a leader in functional neuroimaging technology, made a significant announcement today by unveiling MEG Maps™, a cutting-edge neuroimaging scanner platform. All the components of this platform have received FDA 510(k) clearance, marking a major step forward in...
by MEGIN | Mar 20, 2024 | MEGIN News
EDMONTON, AB – WestCan Proton Therapy Inc. has announced their plans to invest in Canada’s first proton therapy treatment centre to be built in Edmonton. The centre will officially be named in honour of Ben Stelter, beloved six-year-old Edmonton Oilers super-fan and...
by MEGIN | Feb 7, 2024 | MEGIN News
MEGIN was delighted to recently exhibit at the 1st International Epilepsy Surgery Society Congress (IESS) in Dubai, January 19-21, 2024. The IESS event was endorsed by the International League Against Epilepsy (ILAE), in collaboration with the Epilepsy Surgery...
by MEGIN | Dec 2, 2023 | MEGIN News
MEGIN is delighted to announce a partnership with FIND Neuro, a disruptive start-up that reconstructs brain network maps to enable treatment of neurological diseases. FIND Neuro originated at Mass General Hospital and was co-founded by Dr. Noam Peled (CEO), Prof...
by MEGIN | Oct 5, 2023 | MEGIN News
HELSINKI, FINLAND (October 5, 2023) – MEGIN is delighted to announce the sale and installation of our latest magnetoencephalography (MEG) technology, the TRIUX™ neo, to Simon Fraser University’s (SFU) core facility, ImageTech Lab. Located in British Columbia,...
